Type-2 diabetes mellitus (T2DM) is a metabolic disease characterized mainly by hyperglycemia, resulting from defects in β-cell function and/or insulin resistance. Treatment approaches include diet, exercise, and pharmacological agents these however can produce adverse effects such as weight gain and hypoglycemia. Glucagon-like peptide-1 (GLP-1) is a peptide hormone that controls glycaemia and preserves β-cell m...
Financiadores do RCAAP | |||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |